(Press-News.org)
Across the globe, more than 39 million people are living with the Human Immunodeficiency Virus (HIV), the virus that causes AIDS, including more than 1.3 million new HIV diagnoses last year. The majority of those afflicted — approximately 76% — have access to antiviral therapy that allows them to live with HIV as a chronic disease.
Sharilyn Almodóvar, Ph.D., from the Department of Immunology and Molecular Microbiology at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine and the TTUHSC Graduate School of Biomedical Sciences, said that even with the widespread availability of therapy, people living with HIV are facing challenges.
“The good news is that treated patients do not die of AIDS and that HIV is being treated as a chronic disease,” Almodóvar said. “Unfortunately, we still do not have a cure, and the longer people live with HIV, the more susceptible they become to comorbidities that affect their quality of life and may even cause premature death.”
Almodóvar said those comorbidities include neurological and metabolic disorders, liver and kidney diseases, cancers and cardiovascular diseases. They also include pulmonary hypertension, which is currently the focus of her lab’s research. Pulmonary hypertension is a condition in the lungs caused by severe narrowing of the arteries. It increases the pressure in these arteries and affects the right side of the heart, which is not anatomically equipped to handle such high pressures. If the condition progresses without diagnosis or treatment, the result is often death due to right heart failure.
To better understand the role HIV plays in pulmonary hypertension, the National Heart, Lung and Blood Institute at the National Institutes of Health recently awarded Almodóvar a four-year, $2.67 million grant (Role of HIV gp120 and Nef in Transcriptome Dysregulation and Pulmonary Vascular Remodeling) to study how the HIV virus damages the normal interactions between different cell types in the lung arteries that lead to the condition.
“The blood vessels in the lungs are severely affected in the presence of HIV, and this leads to serious illnesses in the lungs and heart,” Almodóvar explained. “In this study, we will conduct experiments to understand how HIV molecules change the way that lung molecules interact so that we can propose novel therapies to prevent lung diseases in people with HIV.”
For this project, Almodóvar will work with a multidisciplinary team that includes co-investigators Igor Ponomarev, Ph.D., and Ebtesam Islam, M.D., Ph.D., from the TTUHSC School of Medicine and the TTUHSC Graduate School of Biomedical Sciences; Michael Melkus, Ph.D., and Jacob Nichols, M.D., from the TTUHSC School of Medicine; Duke Appiah, Ph.D., MPH, from the TTUHSC Julia Jones Matthews School of Population and Public Health and the TTUHSC Graduate School of Biomedical Sciences; and Jeremy Goettel, Ph.D., from Vanderbilt University.
Pulmonary hypertension is relatively rare in the general population but Almodóvar said it is over-represented in people with HIV.
“Years ago, we had the opportunity to study the virus in non-human primates and in patients diagnosed with pulmonary hypertension associated with HIV, and we discovered specific mutations in the virus,” Almodóvar recalled. “With this new study, we will examine how these mutations in the virus damage the normal interactions between different cell types in the lung arteries.”
Almodóvar said one of the study’s novel aspects will be the use of a mouse model with a humanized immune system. These mice allow researchers to study the complex roles of infection, immunodeficiency and pulmonary vascular biology in a system that mimics the physiology of non-human primates.
During this study, the Almodóvar Lab will monitor the infected mice for several weeks to track viral loads (the number of viruses present in the circulation), CD4 cell counts (an indicator of the immune system’s overall health) and inflammatory markers in plasma. Almodóvar said this would not be possible without the support of Scott Trasti, DVM, and the veterinary staff in the TTUHSC Laboratory Animal Resource Center.
“At the end of each experiment, which takes months to complete, we perform right heart catheterizations on these mice to measure their pulmonary arterial pressures and examine their hearts for evidence of heart disease,” Almodóvar said.
The research for this project will occur at the interface of infectious diseases and pulmonary medicine. This provides opportunities for training the next generation of scientists and physician-scientists who are interested in researching this field and are learning how to operate under high biosafety research standards.
“We do not know how HIV causes or contributes to these severe pulmonary vascular diseases,” Almodóvar said. “With these funded studies, we will increase the understanding of how HIV changes the way that the cells in the lung interact with this virus so that we can propose novel therapies to prevent lung diseases in people with HIV.”
###
END
WHO PQ paves the way for public procurement of SKYTyphoid™ by UN organizations
Addition of new vaccine will diversify, expand TCV supply amid expected growing demand
February 23, 2024, SEOUL, Korea – SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.
WHO PQ certifies the safety, efficacy, and GMP of a vaccine by evaluating its manufacturing ...
Should we be using polygenic risk score assessment for embryo selection? Providing in-depth analysis, the Social, Ethical and Legal Issues Committee of the American College of Medical Genetics and Genomics (ACMG) has released a new Points to Consider statement to assist healthcare professionals and patients in understanding the safety and utility of preimplantation genetic testing for polygenic disorders (PGT-P) as a clinical service.
“Clinical Utility of Polygenic Risk Scores for Embryo Selection: A Points to Consider Statement of the American College of Medical Genetics and Genomics (ACMG)” was published in the College’s flagship journal, Genetics ...
Microbially induced corrosion (MIC) is a prevalent issue in marine environments, leading to structural damages such as cracking in concrete infrastructure. This corrosion poses a persistent challenge, significantly reducing the lifespan of marine structures and resulting in substantial economic losses. In response to the need for an effective solution to combat the marine corrosion on concrete, researchers of the Hong Kong Polytechnic University have developed a biomineralization approach to protect marine concrete from MIC.
Prof. ...
Researchers at UBC Okanagan are revisiting old building practices—the use of by-products and cast-offs—as a way to improve building materials and sustainability of the trade.
A technique known as rammed earth construction uses materials that are alternatives to cement and are often more readily available in the environment. One such alternative is wood fly ash, a by-product of pulp mills and coal-fired power plants, explains Dr. Sumi Siddiqua, with UBC Okanagan’s School of Engineering.
Industry has been trying to find a use for materials like fly ash ...
Whiteflies, particularly the African cassava whitefly (Bemisia tabaci, SSA1-SG1), pose a significant threat to agricultural productivity in Sub-Saharan Africa by transmitting viruses that cause cassava brown streak disease and cassava mosaic virus disease. In a new study published in PeerJ Life & Environment, Dr. Tadeo Kaweesi and his team at the National Agricultural Research Organization identify potential gene targets that could revolutionize the management of this devastating pest and prove vital for food security in the region.
In the article ("In silico prediction of candidate gene targets ...
Milan (Italy), 23 February 2024 – TWIN is the name of the new robotic exoskeleton for lower limbs, designed and developed by Rehab Technologies IIT – INAIL, the joint laboratory between the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and the Prosthetic Center of INAIL (the prosthetic unit of the National Institute for Insurance against Accidents at Work), which will allow patients to wear it more easily. Presented today in Milan during a press conference held at the Museum of Science and Technology, TWIN was demonstrated ...
Lockdown drills, practiced to help prepare children for shooting incidents at school, make those who have been exposed to violence feel safer – a new study of thousands of students in the US indicates.
The finding, reported in a new peer-reviewed paper published in the Journal of School Violence, contradicts claims that the drills traumatize children, without making them feel safer.
Ensuring that students feel safe – and are safe – in schools is essential for them to learn and thrive, explains ...
t’s official. Getting the recommended 7-9 hours of sleep a night is currently out of reach for almost one-third of the population as Flinders University experts found 31% of adults had average sleep durations outside the recommended range.
The global study of thousands of adults published in Sleep Health found only 15% of people slept the recommended 7-9 hours for five or more nights per week – and among those who did achieve an average of 7-9 hours per night over the nine month monitoring period, about 40% ...
In recent news, there has been a case where a patient experienced pain due to a surgical procedure involving sutures, resulting in the unintended presence of gauze within the patient's body. Gauze is typically employed to control bleeding during medical interventions, aiding in hemostasis. However, when inadvertently left in the body, it can lead to inflammation and infection. Addressing this issue, recent research has been published by researchers focusing on a hemostatic agent derived from mussels and silkworm cocoons. This hemostatic agent has garnered attention in the academic community due to its efficacy in clotting blood and its safety within ...
A new research study led by A*STAR.Singapore Immunology Network (A*STAR.SIgN) has found that neutrophils—one of the most abundant white blood cells in our body—change drastically in certain cancers, adopting a new function whereby they promote tumour growth. By carefully studying neutrophils as soon as they enter the tumour, scientists from A*STAR.SIgN also uncovered ways to accurately differentiate tumour-promoting neutrophils from normal neutrophils present in the rest of the body. Neutrophils play important and irreplaceable roles in fighting infections, ...
